Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-05-30T14:24:46.522Z Has data issue: false hasContentIssue false
  • English
  • Français

Planned reduction in Fontan fenestration size using the Atrial Flow Regulator

Part of: Interventional Cardiology Hypoplastic Left Heart Syndrome (HLHS)

Published online by Cambridge University Press:  12 April 2021

E. Oliver Aregullin ,
Bennett Samuel Open the ORCID record for Bennett Samuel [Opens in a new window]  and
Joseph Vettukattil
E. Oliver Aregullin
Affiliation:
Congenital Heart Center, Helen DeVos Children’s Hospital, Grand Rapids, Michigan, USA
Bennett Samuel
Affiliation:
Congenital Heart Center, Helen DeVos Children’s Hospital, Grand Rapids, Michigan, USA
Joseph Vettukattil*
Affiliation:
Congenital Heart Center, Helen DeVos Children’s Hospital, Grand Rapids, Michigan, USA
*
Author for correspondence: J. Vettukattil, Congenital Heart Center, Helen DeVos Children’s Hospital, 100 Michigan NE, Grand Rapids, Michigan, USA. Tel: +1 616 267 0988; Fax: +1 616 267 1408; Email: joseph.vettukattil@helendevoschildrens.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Fontan fenestration allows right-to-left shunting increasing cardiac output and oxygen delivery. Increased shunting occurs as cardiac function and ventricular end-diastolic pressures improve, potentially decreasing oxygen saturation. Complete closure may result in impaired Fontan haemodynamics and low cardiac output; however, there are no dedicated devices to reduce fenestration size. We describe Fontan fenestration size reduction using the Atrial Flow Regulator.

Keywords

CHDFontan fenestrationnew devices (in general)paediatric intervention
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 10 , October 2021 , pp. 1690 - 1692
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rychik, J, Atz, AM, Celermajer, DS, et al. Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation 2019; 140: e234–e284.10.1161/CIR.0000000000000696CrossRefGoogle Scholar
Saiki, H, Kuwata, S, Iwamoto, Y, et al. Fenestration in the Fontan circulation as a strategy for chronic cardioprotection. Heart 2018; 105: 1266–1272.10.1136/heartjnl-2018-314183CrossRefGoogle Scholar
Lemler, MS, Scott, WA, Leonard, SR, Stromberg, D, Ramaciotti, C. Fenestration improves clinical outcome of the Fontan procedure: a prospective, randomized study. Circulation 2002; 105: 207–212.CrossRefGoogle ScholarPubMed
Gewillig, M, Boshoff, D. Missing a sub-pulmonary ventricle: the Fontan circulation. In: Voelkel, N, Schranz, D (eds). The Right Ventricle in Health and Disease. Springer, New York, 2014: 135–157.Google Scholar
Rupp, S, Schieke, C, Kerst, G, et al. Creation of a transcatheter fenestration in children with failure of Fontan circulation: Focus on extracardiac conduit connection. Catheter Cardiovasc Interv 2015; 86: 1189–1194.10.1002/ccd.26042CrossRefGoogle ScholarPubMed
Zablah, JE, Morgan, GJ. Use of Occlutech® atrial flow regulator in a single ventricle patient: a 3D view of a successful intervention. Eur Heart J Cardiovasc Imaging 2020; 21: 1151.CrossRefGoogle Scholar
Lehner, A, Schulze-Neick, I, Haas, NA. Creation of a defined and stable Fontan fenestration with the new Occlutech Atrial Flow Regulator (AFR®). Cardiol Young 2018; 28: 1062–1066.CrossRefGoogle Scholar